TriSalus Life Sciences, Inc. (TLSI) Total liabilities 2022–2025
TriSalus Life Sciences, Inc. (TLSI) total liabilities at each fiscal year-end, per SEC filings.
$69.2MFY2025 · since FY2022: $34.3M → $69.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $69.2M | +38.8% |
| FY2024 | $49.9M | -3.5% |
| FY2023 | $51.7M | +50.5% |
| FY2022 | $34.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Net marginTLSI Gross profitTLSI Gross marginTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Shareholders’ equityTLSI overview →